Veterinary Support

Our Pet Technical Services Team of 8 veterinary surgeons and 5 veterinary nurses have over 140 years combined experience. They are committed to helping you provide the best veterinary care through the provision of product advice and clinical case discussion.

Vet Diabetes Helpline: 01344 746957 UK(GB)
Email: vetenquiries@boehringer-ingelheim.com
Service hours: 9am-5pm Mon-Thurs | 9am-4.30pm Fri

Emergencies 24/7 (via telephone only)

Live chat service

If you would like product advice or a clinical case discussion, simply click on the live chat icon on the bottom right of this page to start a conversation with one of our Technical Services Vets.

Case Advice Request Form

Alternatively, you can request a call-back from one of our Pet Technical Services Vets by completing our case advice request form (see below). We endeavour to call you back on your preferred day, and wherever possible, at your preferred time. However, if your enquiry is urgent, please do call the number above.

Download case advice request form

Downloadable content

We have a range of downloadable content for you.

Vet Management Guide

The Vet Management Guide provides all you need to know about managing diabetes in cats with Senvelgo^®

Download

Cat owner leaflet

The cat owner leaflet provides a wealth of information and advice for your clients that have been prescribed Senvelgo^®

Download

Homecare Journal

The Homecare Journal enables your clients to monitor their cats health and ketones at home

Download

Senvelgo^® CPD Webinar

Watch our CPD webinar 'How to best use Senvelgo^® to successfully manage feline diabetes in cats'.

Watch Webinar

References

1. Niessen, S. J. M. et al. (2022) Once daily oral therapy for feline diabetes mellitus: evaluation of SGLT-2 inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats. Journal of Veterinary Internal Medicine 36, 2512–2513.
2. Sparkes, A. H. et al. (2015) ISFM Consensus Guidelines on the Practical Management of Diabetes Mellitus in Cats. J Feline Med Surg 17, 235–50.
3. McCann, T., et al. (2007) Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J Feline Med Surg 9, 289–9.
4. O’Neill, D., et al. (2016) Epidemiology of Diabetes Mellitus among 193,435 Cats Attending Primary-Care Veterinary Practices in England. J Vet Intern Med 30, 964–72.
5. Rand J, Gottlieb, SA. Feline diabetes mellitus. Textbook of Veterinary Internal Medicine, 8th edition. Ettinger SJ, Feldman EC and Cote E, eds. Elsevier, Missouri. 2017;1781-1795.
6. 2018 Summary of the Veterinary Clinic: Pet Obesity Prevalence Survey & Pet Owner: Weight Management, Nutrition, and Pet Food Survey. Available at:
https://petobesityprevention.org/2018.
7. Niessen, S. J. M. et al. (2017) The Big Pet Diabetes Survey: Perceived Frequency and Triggers for Euthanasia. Vet Sci 4, 27.
8. Diabetes in Cats: Quantitative market research study. Proprietary presentation, July 19, 2021. Kynetec; St. Louis, MO, on behalf of Boehringer Ingelheim.
9. Niessen, S. J. M. et al. (2010) Evaluation of a quaility-of-life tool for cats with diabetes mellitus. J Vet Intern Med 24, 1098-105.
10. Behrend, E. N. et al. (2023) Velagliflozin, an SGLT2 Inhibitor, as a once-daily, oral solution, stand-alone therapy for feline diabetes mellitus. Oral abstract presentation, 2023 ACVIM Forum, Pennsylvania, Jun 15-17.
11. Niessen, S. J. M. et al. (2023) Efficacy and safety of once daily oral sodium-glucose co-transporter-2-inhibitor velagliflozin compared to twice daily insulin injection therapy in diabetic cats. Oral abstract presentation, 2023 ECVIM-CA Forum, Barcelona, Sept 21-23.
12. VMD. Summary of Product Characteristics (SPC): Senvelgo^® 15mg/ml oral solution for cats (velagliflozin). Veterinary Medicines Directorate, UK.
13. CM Research (2022) Small animal vets UK April 2022. Syndicated Sales Rep Survey.